S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
All the trading advice you’ve ever received boils down to this (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
All the trading advice you’ve ever received boils down to this (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
All the trading advice you’ve ever received boils down to this (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
All the trading advice you’ve ever received boils down to this (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
All the trading advice you’ve ever received boils down to this (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver

Global Medical REIT Stock Price, News & Analysis (NYSE:GMRE)

$10.34
+0.31 (+3.09%)
(As of 12/1/2023 ET)
Compare
Today's Range
$9.99
$10.34
50-Day Range
$8.44
$10.34
52-Week Range
$8.04
$11.79
Volume
357,234 shs
Average Volume
270,114 shs
Market Capitalization
$677.94 million
P/E Ratio
41.36
Dividend Yield
8.12%
Price Target
$11.50

Global Medical REIT MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
11.2% Upside
$11.50 Price Target
Short Interest
Bearish
2.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-3.19
Upright™ Environmental Score
News Sentiment
0.32mentions of Global Medical REIT in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
2.33%
From $0.86 to $0.88 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.99 out of 5 stars

Finance Sector

502nd out of 846 stocks

Real Estate Investment Trusts Industry

93rd out of 175 stocks


GMRE stock logo

About Global Medical REIT Stock (NYSE:GMRE)

Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

GMRE Stock Price History

GMRE Stock News Headlines

GMRE.PR.A Global Medical REIT Inc. 7.50% CUM PFD A
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Q3 2023 Global Medical REIT Inc Earnings Call
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Plymouth Industrial (PLYM) Meets Q3 FFO Estimates
CTO Realty (CTO) Q3 FFO and Revenues Beat Estimates
Q2 2023 Global Medical REIT Inc Earnings Call
See More Headlines
Receive GMRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/04/2022
Ex-Dividend for 10/10 Dividend
9/21/2023
Dividend Payable
10/10/2023
Today
12/02/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/27/2024

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
N/A
Sector
Finance
Fax
N/A
Employees
29
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.50
High Stock Price Target
$12.50
Low Stock Price Target
$11.00
Potential Upside/Downside
+11.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$19.14 million
Pretax Margin
15.95%

Debt

Sales & Book Value

Annual Sales
$137.28 million
Cash Flow
$1.15 per share
Book Value
$8.52 per share

Miscellaneous

Free Float
60,385,000
Market Cap
$677.99 million
Optionable
Optionable
Beta
1.12
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Jeffery M. Busch (Age 63)
    Chairman, Pres & CEO
    Comp: $979.22k
  • Mr. Robert J. Kiernan CPA (Age 57)
    CFO & Treasurer
    Comp: $559.16k
  • Ms. Danica C. Holley (Age 50)
    Chief Operating Officer
    Comp: $417.86k
  • Mr. Alfonzo Leon (Age 47)
    Chief Investment Officer
    Comp: $521.88k
  • Mr. Jamie A. Barber (Age 46)
    Gen. Counsel & Corp. Sec.
    Comp: $389.64k
  • Ms. Mary Jensen
    Investor Relations Professional














GMRE Stock Analysis - Frequently Asked Questions

Should I buy or sell Global Medical REIT stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GMRE shares.
View GMRE analyst ratings
or view top-rated stocks.

What is Global Medical REIT's stock price target for 2024?

1 Wall Street research analysts have issued 1 year price objectives for Global Medical REIT's stock. Their GMRE share price targets range from $11.00 to $12.50. On average, they expect the company's share price to reach $11.50 in the next twelve months. This suggests a possible upside of 11.2% from the stock's current price.
View analysts price targets for GMRE
or view top-rated stocks among Wall Street analysts.

How have GMRE shares performed in 2023?

Global Medical REIT's stock was trading at $9.48 at the beginning of 2023. Since then, GMRE shares have increased by 9.1% and is now trading at $10.34.
View the best growth stocks for 2023 here
.

Are investors shorting Global Medical REIT?

Global Medical REIT saw a increase in short interest in November. As of November 15th, there was short interest totaling 1,310,000 shares, an increase of 13.9% from the October 31st total of 1,150,000 shares. Based on an average daily volume of 289,600 shares, the days-to-cover ratio is currently 4.5 days.
View Global Medical REIT's Short Interest
.

When is Global Medical REIT's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our GMRE earnings forecast
.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc. (NYSE:GMRE) released its quarterly earnings results on Wednesday, May, 4th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by $0.19. Global Medical REIT had a net margin of 12.09% and a trailing twelve-month return on equity of 3.10%. During the same quarter in the previous year, the company earned $0.24 EPS.

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT announced a quarterly dividend on Friday, September 8th. Stockholders of record on Friday, September 22nd will be paid a dividend of $0.21 per share on Tuesday, October 10th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 8.12%. The ex-dividend date of this dividend is Thursday, September 21st.
Read our dividend analysis for GMRE
.

Is Global Medical REIT a good dividend stock?

Global Medical REIT (NYSE:GMRE) pays an annual dividend of $0.84 per share and currently has a dividend yield of 8.43%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 336.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, GMRE will have a dividend payout ratio of 95.45% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for GMRE.

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Principal Financial Group (PFG), INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Block (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

When did Global Medical REIT IPO?

(GMRE) raised $130 million in an IPO on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by many different institutional and retail investors. Top institutional investors include Brown Advisory Inc. (2.17%), Royal Bank of Canada (1.86%), Invesco Ltd. (1.57%), Sound Income Strategies LLC (1.39%), State of New Jersey Common Pension Fund D (1.33%) and Stifel Financial Corp (1.28%). Insiders that own company stock include Henry Cole and Jeffrey Busch.
View institutional ownership trends
.

How do I buy shares of Global Medical REIT?

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:GMRE) was last updated on 12/3/2023 by MarketBeat.com Staff

My Account -